Literature DB >> 18412103

Identification of neurogenetic pathways of risk for psychopathology.

Patrick M Fisher1, Karen E Muñoz, Ahmad R Hariri.   

Abstract

Imaging genetics has been a highly effective and increasingly applied strategy for identifying the impact of genetic polymorphisms on individual differences in neural circuitry supporting complex behaviors. The application of imaging genetics towards further elucidating neural circuitry associated with the pathophysiology of psychiatric illness is of particular interest given its potential to guide the development and improvement of current therapeutic methods. The identification of genetic variants that contribute to or predict the disruption of specific neural pathways associated with psychopathology may also serve as useful markers of risk demarcating individuals with elevated susceptibility for psychiatric illness and affording early or even preemptive treatment strategies. In the continued development of this technique, recent multimodal neuroimaging strategies and studies examining the effects of multiple genes in concert within large subject populations have shown promise in the development of a more complete understanding of the interrelationships between genes, brain function, behavior and associated risk for psychopathology. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18412103      PMCID: PMC2755190          DOI: 10.1002/ajmg.c.30173

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  47 in total

Review 1.  Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign.

Authors:  Charles E Glatt; Nelson B Freimer
Journal:  Trends Genet       Date:  2002-06       Impact factor: 11.639

2.  No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.

Authors:  Kunihiko Shioe; Tetsuya Ichimiya; Tetsuya Suhara; Akihiro Takano; Yasuhiko Sudo; Fumihiko Yasuno; Masami Hirano; Manabu Shinohara; Masato Kagami; Yoshiro Okubo; Masahiro Nankai; Shigenobu Kanba
Journal:  Synapse       Date:  2003-06-15       Impact factor: 2.562

3.  Amygdala response to fearful faces in anxious and depressed children.

Authors:  K M Thomas; W C Drevets; R E Dahl; N D Ryan; B Birmaher; C H Eccard; D Axelson; P J Whalen; B J Casey
Journal:  Arch Gen Psychiatry       Date:  2001-11

4.  Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT.

Authors:  C H van Dyck; R T Malison; J P Seibyl; M Laruelle; H Klumpp; S S Zoghbi; R M Baldwin; R B Innis
Journal:  Neurobiol Aging       Date:  2000 Jul-Aug       Impact factor: 4.673

5.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 6.  Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing.

Authors:  Ahmad R Hariri; Emily M Drabant; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2006-01-25       Impact factor: 13.382

7.  Is correction for age necessary in neuroimaging studies of the central serotonin transporter?

Authors:  Swen Hesse; Henryk Barthel; Toshiya Murai; Ulrich Müller; Dominic Müller; Anita Seese; Regine Kluge; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-16       Impact factor: 9.236

8.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

9.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety.

Authors:  J A Schinka; R M Busch; N Robichaux-Keene
Journal:  Mol Psychiatry       Date:  2004-02       Impact factor: 15.992

View more
  8 in total

1.  Reward-Modulated Response Inhibition, Cognitive Shifting, and the Orbital Frontal Cortex in Early Adolescence.

Authors:  Zu Wei Zhai; Stefan Pajtek; Beatriz Luna; Charles F Geier; Ty A Ridenour; Duncan B Clark
Journal:  J Res Adolesc       Date:  2014-09-13

Review 2.  Genetic influences on the neural and physiological bases of acute threat: A research domain criteria (RDoC) perspective.

Authors:  Jennifer A Sumner; Abigail Powers; Tanja Jovanovic; Karestan C Koenen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-09-17       Impact factor: 3.568

3.  Genetic variation in neuregulin1 is associated with differences in prefrontal engagement in children.

Authors:  Andrea Mechelli; Essi Viding; William Pettersson-Yeo; Stefania Tognin; Philip K McGuire
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

Review 4.  Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans.

Authors:  Patrick M Fisher; Ahmad R Hariri
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

5.  Imaging genetics.

Authors:  Andrew J Gerber; Bradley S Peterson; Karen E Muñoz; Luke W Hyde; Ahmad R Hariri
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-04       Impact factor: 8.829

Review 6.  Developmental imaging genetics: linking dopamine function to adolescent behavior.

Authors:  Aarthi Padmanabhan; Beatriz Luna
Journal:  Brain Cogn       Date:  2013-10-17       Impact factor: 2.310

7.  Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features.

Authors:  Antonio Drago; Ioannis Liappas; Carmine Petio; Diego Albani; Gianluigi Forloni; Petros Malitas; Christina Piperi; Antonis Politis; Elias O Tzavellas; Katerina K Zisaki; Francesca Prato; Sara Batelli; Letizia Polito; Diana De Ronchi; Thomas Paparrigopoulos; Anastasios Kalofoutis; Alessandro Serretti
Journal:  Int J Environ Res Public Health       Date:  2009-07-16       Impact factor: 3.390

8.  The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.

Authors:  Francesco Fera; Luca Passamonti; Antonio Cerasa; Maria Cecilia Gioia; Maria Liguori; Ida Manna; Paola Valentino; Aldo Quattrone
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.